(Q53372289)

13 May 2018

title

Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards (English)

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

2 June 2024

author name string

A. Ledur

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594617

2 June 2024

C. Fitting

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594617

2 June 2024

B. David

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594617

2 June 2024

C. Hamberger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594617

2 June 2024

J. M. Cavaillon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7594617

2 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7594617

2 June 2024

publication date

1 October 1995

1 reference

13 May 2018

26 October 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7594617

full work available at URL

2 June 2024

https://api.elsevier.com/content/article/PII:002217599500184C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

https://api.elsevier.com/content/article/PII:002217599500184C?httpAccept=text/plain

2 June 2024

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Journal of Immunological Methods

2 June 2024

published in

1 reference

13 May 2018

volume

186

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

171-179

1 reference

13 May 2018

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters

2 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages

2 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Assaying tumor necrosis factor concentrations in human serum. A WHO International Collaborative study

2 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

ELISA kits based on monoclonal antibodies do not measure total IL-1 beta synthesis

2 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Cytokine measurements in septic shock

2 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids

2 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy

2 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

The international standard for interleukin-6. Evaluation in an international collaborative study

2 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

O - and N -glycosylation lead to different molecular mass forms of human monocyte interleukin-6

2 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

ELISA detection of IL-1 beta in human sera needs independent confirmation. False positives in hospitalized patients

2 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue

2 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Pitfalls in measuring cytokines

2 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Inactivation of interleukin-6 in vitro by monoblastic U937 cell plasma membranes involves both protease and peptidyl-transferase activities

2 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Cytokines--protein structure and biological activity: a complex relationship with implications for biological assays and standardization

2 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Bioactive and inactive forms of tumor necrosis factor-alpha in spinal fluid from patients with meningitis

2 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Dissociation between plasma and monocyte-associated cytokines during sepsis

2 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Studies on the role of tumor necrosis factor in adult respiratory distress syndrome

2 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

The international standards for interleukin-1 alpha and interleukin-1 beta. Evaluation in an international collaborative study

2 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Cathepsin-G and leukocyte elastase inactivate human tumor necrosis factor and lymphotoxin

2 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Binding of cytokines to pharmaceutically prepared human immunoglobulin

2 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients

2 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/0022-1759(95)00184-C

2 June 2024

Identifiers

1 reference

13 May 2018

1 reference

13 May 2018